Quetzal Site 4 is a clinical research site located in Buffalo, New York, United States 14203.
Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.
Quetzal Site 4 has participated in 1 clinical trials with 1 currently active.
Therapeutic areas: Acute Promyelocytic Leukemia (APL), Acute Promyelocytic Leukaemia, Acute Promyelocytic Leukemia With PML-RARA.
Sponsors: Quetzal Therapeutics.
Is this your site? Claim your profile and control the information sponsors and patients see.
Browse all research sites in New York · View every site in Buffalo
Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Quetzal Site 4 has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Quetzal Site 4 has 1 clinical trials on record, with 1 currently active. Their work covers Acute Promyelocytic Leukemia (APL), Acute Promyelocytic Leukaemia, Acute Promyelocytic Leukemia With PML-RARA.
Quetzal Site 4 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.